Form 4: AbbVie Director William H.L. Burnside Reports Acquisition and Disposal of Common Stock

Director William H.L. Burnside reports acquiring 1,203 shares of AbbVie common stock and disposing of an unspecified amount.

Summary

• On May 9, 2025, William H.L. Burnside, a director of AbbVie Inc., reported a transaction involving AbbVie's common stock.
• Burnside acquired 1,203 shares of common stock.
• Burnside also disposed of an unspecified amount of common stock.
• Following the reported transactions, Burnside beneficially owns 26,958 shares of AbbVie common stock.
• Burnside was also awarded restricted stock units under the AbbVie Amended and Restated 2013 Incentive Stock Program, which will be paid out in shares of AbbVie common stock upon separation from service, death, or a change in control.

Sentiment

Score: 5

Explanation: This is a routine regulatory filing, so the sentiment is neutral.

Future Outlook

The restricted stock units will be paid out in shares of AbbVie common stock on the earlier of the director's separation from service, death, or the occurrence of a change in control.

Industry Context

Form 4 filings are routine disclosures required by the SEC to provide transparency into the transactions of company insiders, allowing investors to monitor the actions of those with privileged information.

Key Dates

Keywords

AbbVie, ABBV, Director, William H.L. Burnside, Form 4, Stock, Restricted Stock Units, Beneficial Ownership, Transaction